MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Safety and efficacy of treadmill training combined with music on motor outcomes in patients with Parkinson’s disease: A systematic review.

    M. Shahien, A. Azzam, A. Ramadan, D. Hasan, A. Elaraby (Cairo, Egypt)

    Objective: To evaluate the efficacy and safety of the treadmill plus music combined rehabilitation training on motor outcomes in participants with Parkinson’s disease. Background: Parkinson’s…
  • 2022 International Congress

    Long-term wearable tele-rehabilitation of gait for persons with Parkinson’s disease: A feasibility study

    G. Lopane, M. Corzani, I. D'Ascanio, V. Petrone, M. Contin, G. Calandra Buonaura, P. Cortelli, F. La Porta, M. Brozgol, N. Giladi, PC. Thumm, JM. Hausdorff, L. Chiari, L. Palmerini (Bologna, Italy)

    Objective: This study aims to evaluate the feasibility of long-term wearable tele-rehabilitation of gait in people with Parkinson’s disease. Background: Tele-rehabilitation allows patients to utilize…
  • 2022 International Congress

    The cross-talk between microglia-derived exosomes and brain printing biometrics as a diagnostic approach for Parkinson’s disease prior to motor symptoms implications

    M. Anwar, M. Fathi (Cairo, Egypt)

    Objective: To highlight the efficiency of using microglia-derived exosomes (MDEs) in cross-talk with the BPB technique for the early diagnosis of Parkinson’s disease (PD) Background:…
  • 2022 International Congress

    Lateral shifting from apomorphine subcutaneous infusion (ASI) to levodopa-carbidopa intestinal gel (LCIG) in the treatment of advanced idiopathic Parkinson’s disease (PD): Case series

    M. Abu Al-Melh, M. Farghal, N. Abdelall (Ahmadi governorate, Kuwait)

    Objective: To report our experience with transitioning from apomorphine subcutaneous infusion (ASI) to levodopa-carbidopa intestinal gel (LCIG) in two patients with advanced idiopathic Parkinson’s disease (PD). Background: Device-assisted…
  • 2022 International Congress

    Correlation between cognitive/emotional factors and postural control in patients with Parkinson’s disease

    A. Bitiati, C. de Oliveira, C. de Souza, A. Batista, R. Marquesini, A. Moreira-Neto, C. Batista, L. Teixeira, A. Pardini, D. Coelho (Santo André, Brazil)

    Objective: This study aims to find associations between executive function, anxiety, depression, and reactive and anticipatory postural control domains. Background: Cognition and emotional state are…
  • 2022 International Congress

    Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body disease.

    L. Wright, P. Donaghy, D. Burn, J-P. Taylor, J. O'Brien, A. Yarnall, F. Matthews, M. Firbank, A. Thomas, R. Lawson (Newcastle upon Tyne, United Kingdom)

    Objective: To investigate the influence of neuropsychiatric symptoms (NPS) on early cognitive decline in patients with Lewy body disease (LBD). Background: NPS in LBD, including…
  • 2022 International Congress

    Association between longitudinal degeneration of the cholinergic basal forebrain and cognition-relevant cortical areas in early-stage PD

    M. Labrador-Espinosa, J. Silva-Rodríguez, P. Mir, M. Grothe (Sevilla, Spain)

    Objective: To examine whether the association between longitudinal cBF degeneration and cognitive decline in PD is mediated by parallel atrophy of cortical areas. Background: Degeneration…
  • 2022 International Congress

    New-onset Parkinsonism after Covid-19: is there a link? A 2022 report of clinical cases

    I. Boura, V. Leta, K. Rukavina, V. Raeder, C. Falup Pecurariu, M. Rodriguez-Violante, A. Antonini, K. Ray Chaudhuri (Heraklion, Greece)

    Objective: To document the phenotypic range and nature of all published cases of new-onset parkinsonism developing with or shortly after a reported Severe Acute Respiratory…
  • 2022 International Congress

    Parkinson’s disease symptom asymmetry at disease onset corresponds to low-beta power asymmetry in the subthalamic nucleus

    A. Buijink, F. Torrecillos, M. Stam, D. Piña-Fuentes, A. Pogosyan, C. Wiest, R. de Bie, P. Schuurman, G. Tinkhauser, H. Tan, M. Beudel (Amsterdam, Netherlands)

    Objective: Compare beta-power in the subthalamic nucleus (STN) between the most affected and least affected body side at disease onset. Background: Exaggerated beta activity (13–35…
  • 2022 International Congress

    Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in REM Sleep Behavior Disorder

    C. Tan, H. Nawaz, S. Lageman, B. Berman, N. Mukhopadhyay, M. Barrett (Richmond, USA)

    Objective: To determine if there is evidence of cholinergic basal forebrain degeneration, i.e., reduced cholinergic nucleus 4 (Ch4) volume on MRI, in patients with REM…
  • « Previous Page
  • 1
  • …
  • 108
  • 109
  • 110
  • 111
  • 112
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #24970 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley